AI Visibility Scorecard
acgenetic.com · Healthcare
Borderline visible. AI bots can crawl AcGenetic Therapeutics, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.
AI engines read this profile 10 times
Meta AI · Claude · Apple Intelligence
#236,096 of 924,420 in Healthcare for AI visibility
<1
4
AEO Visibility
iBorderline · 4/10
5
Muse Index Score
iAI agent readiness
Basic · 5/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
AcGenetic Therapeutics describes itself simply: "LGMD 2B/R2, also known as dysferlinopathy, is a rare genetic muscle disorder caused by mutations in the DYSF gene." When AI engines look at it, they find little to work with. It scores 4.0 out of 10.
Our crawl found a sitemap and a readable heading structure. It is missing structured data describing the business and an llms.txt file.
AI crawlers have visited 7 times in our tracking, including ClaudeBot (Anthropic), Applebot (Siri) and Meta AI.
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Fair
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Fair
Experience, Expertise, Authority, Trust markers.
Technical AEO
Good
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Weak
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Weak
No inbound links found yet.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 4/10, AcGenetic Therapeutics is crawlable but under-signaled - fixable, and the signals above are where to start.
What is LGMD 2B/R2?
LGMD 2B/R2, also known as dysferlinopathy, is a rare genetic muscle disorder caused by mutations in the DYSF gene. It leads to progressive muscle weakness and wasting, primarily affecting the muscles of the hips, shoulders, and limbs. Symptoms often begin in late adolescence or early adulthood, and the condition gradually worsens over time. LGMD 2B/R2 is inherited in an autosomal recessive pattern.
Why is LGMD 2B/R2 first?
The founder of this company is a patient with LGMD 2B/R2, as are his siblings. His firsthand experience as a patient and as a brother of other patients drives his deep commitment to advancing research in this field. He is also personally contributing to the research by providing his fibroblasts sample for the generation of stem cells, and by participating as a volunteer patient.
How to cure LGMD 2B/R2?
There have been numerous efforts to develop treatments to cure or alleviate the symptoms of LGMD 2B/R2. However, no significant solution has yet been established for this rare disease.
Is this your brand?
The exact fixes for AcGenetic Therapeutics
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
Already have an account? Sign in
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for AcGenetic Therapeutics.
Scored by Engagemii on August 6, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/acgenetic
Cite this score: Engagemii (2026). "AEO Score for AcGenetic Therapeutics." Retrieved from https://engagemii.com/aeo/brands/acgenetic
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform